At Roivant Discovery we have assembled a diverse leadership team with extensive experience across disciplines ranging from physics and computer-aided drug design to chemistry and structural biology. This continuum of complementary experience is essential for driving our scientific vision and bringing innovative therapeutics to patients in need.
Matt Maisak, Ph.D.
Chief Operating Officer, Roivant Platforms
Woody Sherman, Ph.D.
Chief Computational Scientist
Pamela Carroll, Ph.D.
Chief Business Officer
Iván Cornella-Taracido, Ph.D.
Vice President of Translational Chemical Biology
Huafeng Xu, Ph.D.
Chief Technology Officer
Eric Valeur, Ph.D.
Vice President, Head of Drug Discovery
Christopher G. Winter, Ph.D.
Head of Portfolio Strategy
Jason Imbriglio, Ph.D.
Vice President, Discovery Chemistry
Tudor Oprea, M.D., Ph.D.
Vice President, Translational Informatics
Anthony Partridge, Ph.D.
Vice President, Head of Biology and Pharmacology